Loading...
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
BACKGROUND: The use of neurotrophic factors to treat Alzheimer’s disease (AD) is hindered by their blood–brain barrier impermeability, short half-life, and severe side effects. Peptide 021 (P021) is a neurotrophic/neurogenic tetra-peptide that was derived from the most active region of the ciliary n...
Saved in:
| Published in: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488423/ https://ncbi.nlm.nih.gov/pubmed/28655344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0273-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|